Erivedge Approved to Treat Basal Cell Carinoma (HealthDay)
HealthDay – MONDAY, January 30 (HealthDay News) — Erivedge (vismodegib) has
been approved by the U.S. Food and Drug Administration to treat the most
common form of skin cancer, basal cell carcinoma, the agency said
Monday.